RE: PharmaTex Research10 Mar 2021 21:13
Doc you also have to remember that we have no idea of what’s going on with the p3. They could have started in many countries and we would only know if someone mentioned it on Twitter or it was updated on the trial list, albeit that is very delayed. We have to believe they are making good progress. We also need to remember they only need 600 trialists. I think we worked out that if there is 200 each in uk and USA then the remaining countries only need to recruit circa 11 patients each. So not majorly important the smaller counties are dosed first. I expect they have concentrated on uk and USA first. The other counties are more for selling into on approval if they can also see at first hand the benefit of sng001. Very savvy commercial move but little dependency on the overall numbers to fill the trial.